InvestorsObserver
×
News Home

Will Virios Therapeutics Inc (VIRI) Outperform the Rest of the Stocks in the Healthcare Sector?

Friday, November 10, 2023 01:07 PM | InvestorsObserver Analysts

Mentioned in this article

Will Virios Therapeutics Inc (VIRI) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 94 puts Virios Therapeutics Inc (VIRI) near the top of the Healthcare sector according to InvestorsObserver. Virios Therapeutics Inc's score of 94 means that it ranks higher than 94% of stocks in the sector. In addition, its overall score of 74 ranks it higher than 74% of all stocks.

Overall Score - 74
VIRI has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on VIRI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Virios Therapeutics Inc Stock Today?

Virios Therapeutics Inc (VIRI) stock is trading at $0.90 as of 1:06 PM on Friday, Nov 10, an increase of $0.15, or 20% from the previous closing price of $0.75. The stock has traded between $0.81 and $1.04 so far today. Volume today is above average. So far 1,014,714 shares have traded compared to average volume of 645,998 shares. Click Here to get the full Stock Report for Virios Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App